Considering previously shown direct correlation between overexpressed PAI-1 and the survival in GBM [11], and also its role in being potential serum marker in the prediction of glioma grade [12], we decided to focus our research on PAI-1. This evidence concerns the gene SERPINE1 and central nervous system cancer.